Sort
11,323 grants matching “glioblastoma”
Polynuclear Platinums in Targeted and Combination Glioma Therapy
$254,522Oliver Bogler · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
Phosphoinositide Regulation of Focal Adhesion Structure
$254,516Oregon State University · R01 · FY2002 · GM
Growth inhibition of brain tumors by cord blood stem cells
$254,353Jasti S Rao · University Of Illinois At Chicago · R01 · FY2010 · NS
Tracking the in vivo proliferative history of human glioma-derived stem cells
$254,250Roland Horst Friedel · Icahn School Of Medicine At Mount Sinai · R21 · FY2013 · NS
Contextual Glioblastoma Screening For Efficacious Radiation Sensitizers
$254,250Dimitris G. Placantonakis · New York University School Of Medicine · R21 · FY2014 · NS
Overcoming Resistance to Anti-VEGF Treatment of Glioblastoma
$253,993Rakesh K. Jain · Massachusetts General Hospital · P01 · FY2012 · CA
Biomarkers of survival in glioma epidemiology
$253,843John K. Wiencke · University Of California, San Francisco · R01 · FY2013 · CA
Design of Therapeutic Strategies Specific for Breast Cancer Initiating Cells
$253,788Germana Rappa · Roseman University Of Health Sciences · R01 · FY2012 · CA
Project 3: Circumventing extracellular Adenosine barrier to oncolytic virotherapy
$253,752Balveen Kaur · Brigham And Women'S Hospital · P01 · FY2024 · CA
Cytoplasmic Multimerization of the RNA-binding protein HuR is Oncogenic in Glioma
$253,739Louis B Nabors · University Of Alabama At Birmingham · R01 · FY2019 · CA
Boronated nucleosides for neutron capture therapy of brain tumors
$253,674Werner Tjarks · Ohio State University · R01 · FY2013 · CA
Targeting Translation Control in Malignant Glioma
$253,655Matthias Gromeier · Duke University · R01 · FY2015 · CA
Targeting Translation Control in Malignant Glioma
$253,655Matthias Gromeier · Duke University · R01 · FY2016 · CA
Development of novel synNotch CART cell therapy in adult patients with recurrent EGFRvIII+ glioblastoma
$253,654Hideho Okada · University Of California, San Francisco · U19 · FY2022 · CA
Establishing the role of the atypical kinase ADCK3 in mitochondrial metabolism
$253,634David J Pagliarini · Morgridge Institute For Research, Inc. · R01 · FY2015 · GM
Tracing hypoxic state and hypoxia memory in glioblastoma progression
$253,563Roland Horst Friedel · Icahn School Of Medicine At Mount Sinai · R21 · FY2022 · NS
Dendritic Cell Vaccine Targeting Melanoma-Associated Antigens in Malignant Glioma
$253,548Linda M Liau · University Of California Los Angeles · R01 · FY2007 · CA
Dendritic Cell Vaccine Targeting Melanoma-Associated Antigens in Malignant Glioma
$253,548Linda M Liau · University Of California Los Angeles · R01 · FY2010 · CA
Dendritic Cell Vaccine Targeting Melanoma-Associated Antigens in Malignant Glioma
$253,548Linda M Liau · University Of California Los Angeles · R01 · FY2009 · CA
Dendritic Cell Vaccine Targeting Melanoma-Associated Antigens in Malignant Glioma
$253,548Linda M Liau · University Of California Los Angeles · R01 · FY2008 · CA
Development of novel synNotch CART cell therapy in adult patients with recurrent EGFRvIII+ glioblastoma
$253,519Hideho Okada · University Of California, San Francisco · U19 · FY2023 · CA
Novel CXCR4 Therapeutics to Block Bevacizumab-Induced Glioma Dissemination.
$253,500David Zagzag · New York University School Of Medicine · R21 · FY2011 · NS
Targeting Glioma by Anti-MMPs-2 and -9 DNAzymes
$253,417Tayebeh Pourmotabbed · University Of Tennessee Health Sci Ctr · R01 · FY2006 · CA
Overcoming Resistance to Anti-VEGF Treatment of Glioblastoma
$253,387Rakesh K. Jain · Massachusetts General Hospital · P01 · FY2015 · CA
Overcoming Resistance to Anti-VEGF Treatment of Glioblastoma
$253,386Rakesh K. Jain · Massachusetts General Hospital · P01 · FY2016 · CA